Role of Polycomb Complexes in Normal and Malignant Plasma Cells - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2020

Role of Polycomb Complexes in Normal and Malignant Plasma Cells


Plasma cells (PC) are the main effectors of adaptive immunity, responsible for producing antibodies to defend the body against pathogens. They are the result of a complex highly regulated cell differentiation process, taking place in several anatomical locations and involving unique genetic events. Pathologically, PC can undergo tumorigenesis and cause a group of diseases known as plasma cell dyscrasias, including multiple myeloma (MM). MM is a severe disease with poor prognosis that is characterized by the accumulation of malignant PC within the bone marrow, as well as high clinical and molecular heterogeneity. MM patients frequently develop resistance to treatment, leading to relapse. Polycomb group (PcG) proteins are epigenetic regulators involved in cell fate and carcinogenesis. The emerging roles of PcG in PC differentiation and myelomagenesis position them as potential therapeutic targets in MM. Here, we focus on the roles of PcG proteins in normal and malignant plasma cells, as well as their therapeutic implications.
Fichier principal
Vignette du fichier
ijms-21-08047-v2.pdf (3.84 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03243763 , version 1 (15-11-2021)





Emmanuel Varlet, Sara Ovejero, Anne-Marie Martinez, Giacomo Cavalli, Jerome Moreaux. Role of Polycomb Complexes in Normal and Malignant Plasma Cells. International Journal of Molecular Sciences, 2020, 21 (21), pp.8047. ⟨10.3390/ijms21218047⟩. ⟨hal-03243763⟩
49 Consultations
41 Téléchargements



Gmail Facebook X LinkedIn More